News

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...
East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...
As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...
I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...
VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...
As venture funding becomes concentrated in fewer, larger rounds, a biotech with operations in Newton has secured a ...
It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...
Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...